Tuesday, December 12, 2017

Repros Therapeutics (RPRX) to be acquired by Allergan plc (AGN) for $0.67/share

Repros Therapeutics to be acquired by Allergan plc (AGN) for $0.67/share in cash
  • Pending approvals, Repros anticipates the transaction will close during the first quarter of 2018.
 

 





Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)